SCHEMBL6035592

SCHEMBL6035592

COc1ccc(O)cc1OCc1ccccc1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCHE P06276 2/20 0.63
SMPD1 P17405 2/20 0.61
HDAC1 Q13547 1/20 0.61
HDAC8 Q9BY41 1/20 0.61
HDAC6 Q9UBN7 1/20 0.61
SMN1; SMN2 Q16637 2/20 0.55
NPC1 O15118 1/20 0.55
HPGD P15428 1/20 0.55
RAB9A P51151 1/20 0.55
MAPK1 P28482 1/20 0.55
HSD17B10 Q99714 1/20 0.55
RXRA P19793 1/20 0.54
HTR1A P08908 1/20 0.54
ADRA1D P25100 1/20 0.54
ADRA1A P35348 1/20 0.54
ADRA1B P35368 1/20 0.54
MRGPRX4 Q96LA9 1/20 0.54
ELANE P08246 1/20 0.53
CTSG P08311 1/20 0.53
ATM Q13315 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31444153 1.00 BCHE (0.63) BCHESMPD1HDAC1HDAC8HDAC6
SCHEMBL6881536 0.93 BCHE (0.63) BCHESMN1; SMN2NPC1HPGDRAB9A
SCHEMBL8728948 0.89 SLC2A1 (0.59) BCHEHDAC6SMN1; SMN2NPC1HPGD
SCHEMBL29721165 0.89 SLC2A1 (0.59) BCHEHDAC6SMN1; SMN2NPC1HPGD
SCHEMBL10796837 0.85 KDM4E (0.60) HDAC6SMN1; SMN2NPC1HPGDRAB9A
SCHEMBL7736572 0.84 ABCB1 (0.59) SMN1; SMN2HTR1AADRA1DADRA1AADRA1B
SCHEMBL3239903 0.83 BCHE (0.60) BCHESMPD1HDAC1HDAC8HDAC6
SCHEMBL31361425 0.83 BCHE (0.60) BCHESMPD1HDAC1HDAC8HDAC6
SCHEMBL13791570 0.83 MAOB (0.62) BCHESMPD1HDAC1HDAC8HDAC6
SCHEMBL2090976 0.83 MAOB (0.62) BCHESMPD1HDAC1HDAC8HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025096856-A1 COVALENT CEREBLON LIGANDS C4 THERAPEUTICS, INC. (US) 2025-05-08 WO disclosed
CN-106220487-B A kind of chalcones derivative, preparation method, pharmaceutical composition and application 上海市奉贤区中心医院 2018-10-02 CN disclosed
CN-106220487-A A kind of chalcones derivant, preparation method, pharmaceutical composition and application 上海市奉贤区中心医院 2016-12-14 CN disclosed
US-20070173548-A1 Malonamic acids and derivatives thereof as thyroid receptor ligands CHIANG YUAN-CHING P 2007-07-26 US disclosed
US-20070173548-A1 Malonamic acids and derivatives thereof as thyroid receptor ligands CHIANG YUAN-CHING P 2007-07-26 US disclosed
US-7202275-B2 Malonamic acids and derivatives thereof as thyroid receptor ligands WARNER LAMBERT COMPANY LLC (US) 2007-04-10 US disclosed
US-7202275-B2 Malonamic acids and derivatives thereof as thyroid receptor ligands WARNER LAMBERT COMPANY LLC (US) 2007-04-10 US disclosed
US-20060148858-A1 1, 2-Azole derivatives with hypoglycemic and hypolipidemic activity TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2006-07-06 US disclosed
EP-1513817-A1 1, 2-AZOLE DERIVATIVES WITH HYPOGLYCEMIC AND HYPOLIPIDEMIC ACTIVITY Takeda Pharmaceutical Company Limited (JP) 2005-03-16 EP disclosed
WO-2003099793-A9 1,2-AZOLE DERIVATIVES WITH HYPOGLYCEMIC AND HYPOLIPIDEMIC ACTIVITY TAKEDA PHARMACEUTICAL (JP) 2005-02-10 WO disclosed
US-4633006-A ARTIFICIAL SWEETENERS GENERAL FOODS CORPORATION (US) 1986-12-30 US disclosed
US-4626442-A 3-hydroxy-4-alkyloxyphenyl heterocyclic aromatic carboxylates GENERAL FOODS CORPORATION (US) 1986-12-02 US disclosed
US-4602095-A 3-hydroxy-4-alkyloxyphenyl heterocyclic aromatic carboxylates GENERAL FOODS CORPORATION (US) 1986-07-22 US disclosed
US-4579748-A Foodstuff containing 3-hydroxy-4-methoxyphenyl benzoates GENERAL FOODS CORP. (US) 1986-04-01 US disclosed
US-4547584-A 3-Hydroxy-4-methoxyphenyl benzoates GENERAL FOODS CORPORATION (US) 1985-10-15 US disclosed
US-4546000-A 3-Hydroxy-4-alkyloxyphenyl aliphatic carbonates GENERAL FOODS CORPORATION (US) 1985-10-08 US disclosed
US-4545999-A 3-Hydroxy-4-methoxyphenyl aryl carbonates GENERAL FOODS CORPORATION (US) 1985-10-08 US disclosed
US-4544566-A 3-Hydroxy-4-alkyloxyphenyl heterocyclic carbonates GENERAL FOODS CORPORATION (US) 1985-10-01 US disclosed
EP-0151293-A2 3-hydroxy-4-methoxyphenyl benzoates, process for modifying the sweetness perception in a foodstuff and foodstuff compositions containing said sweetening agents GENERAL FOODS CORPORATION (US) 1985-08-14 EP disclosed
EP-0146913-A2 3-hydroxy-4-alkyloxyphenyl heterocyclic aromatic carboxylates, foodstuffs containing said compounds as sweetening agents and process for modifying the sweetness perception in a foodstuff GENERAL FOODS CORPORATION (US) 1985-07-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060148858-A1 1, 2-Azole derivatives with hypoglycemic and hypolipidemic activity GPR119, SLC5A1, CYP4B1 BCHE 1107/4885SMPD1 2000/4885HDAC1 398/4885
US-20070173548-A1 Malonamic acids and derivatives thereof as thyroid receptor ligands THRA, MC1R, TSHR BCHE 1300/4885SMPD1 3118/4885HDAC1 466/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.